Cytodyn Inc (CYDY)

[3X Charm]

Au contraire…The most important trial results ARE…HITTING THE ENDPOINTS!

Cytodyn has not done that in the CoVID trials and is struggling mightily to fill BRAZIL trials which were touted as a sure thing. LMAO.

THE ONLY SURE THING WITH CYDY IS THAT NADER AND INSIDERS GET PAID!

The facts are the mortality rate of CoVID, from a medical perspective, is nominal and effective treatments are emerging to treat most cases. (Not minimizing individual CoVID horror stories, looking at the economics)

The CoVID play is history. No results possible until end of 2022 with the pace of the Brazil trial enrollment.

Enrollment is as mush as 5 times slower than expected.

The road to cancer and NASH will be long and difficult. HIV was a lock and somehow Nader pulled defeat from the jaws of victory. ( Oh yeah, he won about $15mil worth from that fiasco).

Nader does not possess the skills necessary to compete in cancer.